Search research articles
Contact Us
Filters
Showing results (271-280 of 373) with videos related to
Page
of 38
Sort By:
The Lancet. Haematology
|
March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
International Journal of Molecular Sciences
|
November 24, 2019
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
Tobias Gluexam, Alexander M Grandits, Angela Schlerka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
Johannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Hepatology Communications
|
February 5, 2024
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
JAMA Oncology
|
February 5, 2026
BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma
Justin Ferdinandus, Horst Müller, Janina Jablonski, et al.
The Lancet. Oncology
|
September 11, 2016
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
Stefanie Kreissl, Horst Mueller, Helen Goergen, et al.
Gastroenterology
|
September 21, 2010
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy
Jasmohan S Bajaj, Douglas M Heuman, James B Wade, et al.
Leukemia
|
August 19, 2021
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
Carla Damaschin, Helen Goergen, Stefanie Kreissl, et al.
Journal of Hepatology
|
May 14, 2013
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis
Vishwadeep Ahluwalia, James B Wade, Leroy Thacker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 26, 2019
Alterations in Skin Microbiomes of Patients With Cirrhosis
Jasmohan S Bajaj, Andrew Fagan, Masoumeh Sikaroodi, et al.
Page
of 38
Search research articles
Search
Showing results (271-280 of 373) with videos related to
Sort By:
Page
of 38
The Lancet. Haematology
|
March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
International Journal of Molecular Sciences
|
November 24, 2019
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
Tobias Gluexam, Alexander M Grandits, Angela Schlerka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
Johannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Hepatology Communications
|
February 5, 2024
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
JAMA Oncology
|
February 5, 2026
BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma
Justin Ferdinandus, Horst Müller, Janina Jablonski, et al.
The Lancet. Oncology
|
September 11, 2016
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
Stefanie Kreissl, Horst Mueller, Helen Goergen, et al.
Gastroenterology
|
September 21, 2010
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy
Jasmohan S Bajaj, Douglas M Heuman, James B Wade, et al.
Leukemia
|
August 19, 2021
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
Carla Damaschin, Helen Goergen, Stefanie Kreissl, et al.
Journal of Hepatology
|
May 14, 2013
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis
Vishwadeep Ahluwalia, James B Wade, Leroy Thacker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 26, 2019
Alterations in Skin Microbiomes of Patients With Cirrhosis
Jasmohan S Bajaj, Andrew Fagan, Masoumeh Sikaroodi, et al.
Page
of 38